1h Free Analyst Time
The global pruritus drugs market is forecasted to grow by USD 6.79 billion during 2025-2030, accelerating at a CAGR of 7.2% during the forecast period. The report on the global pruritus drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of chronic systemic and dermatological diseases, robust clinical pipelines and advancements in targeted biologic therapies, strategic licensing agreements and high value acquisitions expanding global reach.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The global pruritus drugs market is segmented as below:
By Application
- Hematologic pruritus
- Oncological pruritus
- Renal pruritus
- Endocrine pruritus
- Cholestatic pruritus
By Route Of Administration
- Oral
- Topical
- Injectable
- Others
By End-User
- Hospitals
- Homecare
- Specialty Clinics
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (RoW)
- Rest of World (RoW)
The report on the global pruritus drugs market covers the following areas:
- Global pruritus drugs market sizing
- Global pruritus drugs market forecast
- Global pruritus drugs market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Chart on Overview on criticality of inputs and factors of differentiation
- Chart on Overview on factors of disruption
- Chart on Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
- Chart on Parent Market
- Data Table on - Parent Market
- Chart on Market characteristics analysis
- Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
4.4 Market outlook: Forecast for 2025-2030
- Data Table on Offerings of companies included in the market definition
- Market segments
4.4 Market outlook: Forecast for 2025-2030
- Chart on Global - Market size and forecast 2025-2030 ($ million)
- Data Table on Global - Market size and forecast 2025-2030 ($ million)
- Chart on Global Market: Year-over-year growth 2025-2030 (%)
- Data Table on Global Market: Year-over-year growth 2025-2030 (%)
5 Historic Market Size
5.1 Global Pruritus Drugs Market 2020 - 2024
- Historic Market Size - Data Table on Global Pruritus Drugs Market 2020 - 2024 ($ million)
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
- Historic Market Size - End-user Segment 2020 - 2024 ($ million)
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
6.1 Impact of AI on Global Pruritus Drugs Market
6.2 Impact of geopolitical conflict on Global Pruritus Drugs Market
6.2 Impact of geopolitical conflict on Global Pruritus Drugs Market
7 Five Forces Analysis
7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- Threat of new entrants - Impact of key factors in 2025 and 2030
- Threat of substitutes - Impact of key factors in 2025 and 2030
- Threat of rivalry - Impact of key factors in 2025 and 2030
- Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Application
8.1 Market segments
- Chart on Application - Market share 2025-2030 (%)
- Data Table on Application - Market share 2025-2030 (%)
- Chart on Comparison by Application
- Data Table on Comparison by Application
- Chart on Hematologic pruritus - Market size and forecast 2025-2030 ($ million)
- Data Table on Hematologic pruritus - Market size and forecast 2025-2030 ($ million)
- Chart on Hematologic pruritus - Year-over-year growth 2025-2030 (%)
- Data Table on Hematologic pruritus - Year-over-year growth 2025-2030 (%)
- Chart on Oncological pruritus - Market size and forecast 2025-2030 ($ million)
- Data Table on Oncological pruritus - Market size and forecast 2025-2030 ($ million)
- Chart on Oncological pruritus - Year-over-year growth 2025-2030 (%)
- Data Table on Oncological pruritus - Year-over-year growth 2025-2030 (%)
- Chart on Renal pruritus - Market size and forecast 2025-2030 ($ million)
- Data Table on Renal pruritus - Market size and forecast 2025-2030 ($ million)
- Chart on Renal pruritus - Year-over-year growth 2025-2030 (%)
- Data Table on Renal pruritus - Year-over-year growth 2025-2030 (%)
- Chart on Endocrine pruritus - Market size and forecast 2025-2030 ($ million)
- Data Table on Endocrine pruritus - Market size and forecast 2025-2030 ($ million)
- Chart on Endocrine pruritus - Year-over-year growth 2025-2030 (%)
- Data Table on Endocrine pruritus - Year-over-year growth 2025-2030 (%)
- Chart on Cholestatic pruritus - Market size and forecast 2025-2030 ($ million)
- Data Table on Cholestatic pruritus - Market size and forecast 2025-2030 ($ million)
- Chart on Cholestatic pruritus - Year-over-year growth 2025-2030 (%)
- Data Table on Cholestatic pruritus - Year-over-year growth 2025-2030 (%)
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
9 Market Segmentation by Route of Administration
9.1 Market segments
- Chart on Route of Administration - Market share 2025-2030 (%)
- Data Table on Route of Administration - Market share 2025-2030 (%)
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- Chart on Oral - Market size and forecast 2025-2030 ($ million)
- Data Table on Oral - Market size and forecast 2025-2030 ($ million)
- Chart on Oral - Year-over-year growth 2025-2030 (%)
- Data Table on Oral - Year-over-year growth 2025-2030 (%)
- Chart on Topical - Market size and forecast 2025-2030 ($ million)
- Data Table on Topical - Market size and forecast 2025-2030 ($ million)
- Chart on Topical - Year-over-year growth 2025-2030 (%)
- Data Table on Topical - Year-over-year growth 2025-2030 (%)
- Chart on Injectable - Market size and forecast 2025-2030 ($ million)
- Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
- Chart on Injectable - Year-over-year growth 2025-2030 (%)
- Data Table on Injectable - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by End-user
10.1 Market segments
- Chart on End-user - Market share 2025-2030 (%)
- Data Table on End-user - Market share 2025-2030 (%)
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
- Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
- Chart on Hospitals - Year-over-year growth 2025-2030 (%)
- Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
- Chart on Homecare - Market size and forecast 2025-2030 ($ million)
- Data Table on Homecare - Market size and forecast 2025-2030 ($ million)
- Chart on Homecare - Year-over-year growth 2025-2030 (%)
- Data Table on Homecare - Year-over-year growth 2025-2030 (%)
- Chart on Specialty Clinics - Market size and forecast 2025-2030 ($ million)
- Data Table on Specialty Clinics - Market size and forecast 2025-2030 ($ million)
- Chart on Specialty Clinics - Year-over-year growth 2025-2030 (%)
- Data Table on Specialty Clinics - Year-over-year growth 2025-2030 (%)
- Chart on Others - Market size and forecast 2025-2030 ($ million)
- Data Table on Others - Market size and forecast 2025-2030 ($ million)
- Chart on Others - Year-over-year growth 2025-2030 (%)
- Data Table on Others - Year-over-year growth 2025-2030 (%)
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
11 Customer Landscape
11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
- Chart on Market share by geography 2025-2030 (%)
- Data Table on Market share by geography 2025-2030 (%)
- Chart on Geographic comparison
- Data Table on Geographic comparison
- Chart on North America - Market size and forecast 2025-2030 ($ million)
- Data Table on North America - Market size and forecast 2025-2030 ($ million)
- Chart on North America - Year-over-year growth 2025-2030 (%)
- Data Table on North America - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - North America
- Data Table on Regional Comparison - North America
- Chart on US - Market size and forecast 2025-2030 ($ million)
- Data Table on US - Market size and forecast 2025-2030 ($ million)
- Chart on US - Year-over-year growth 2025-2030 (%)
- Data Table on US - Year-over-year growth 2025-2030 (%)
- Chart on Canada - Market size and forecast 2025-2030 ($ million)
- Data Table on Canada - Market size and forecast 2025-2030 ($ million)
- Chart on Canada - Year-over-year growth 2025-2030 (%)
- Data Table on Canada - Year-over-year growth 2025-2030 (%)
- Chart on Mexico - Market size and forecast 2025-2030 ($ million)
- Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
- Chart on Mexico - Year-over-year growth 2025-2030 (%)
- Data Table on Mexico - Year-over-year growth 2025-2030 (%)
- Chart on Europe - Market size and forecast 2025-2030 ($ million)
- Data Table on Europe - Market size and forecast 2025-2030 ($ million)
- Chart on Europe - Year-over-year growth 2025-2030 (%)
- Data Table on Europe - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Europe
- Data Table on Regional Comparison - Europe
- Chart on Germany - Market size and forecast 2025-2030 ($ million)
- Data Table on Germany - Market size and forecast 2025-2030 ($ million)
- Chart on Germany - Year-over-year growth 2025-2030 (%)
- Data Table on Germany - Year-over-year growth 2025-2030 (%)
- Chart on UK - Market size and forecast 2025-2030 ($ million)
- Data Table on UK - Market size and forecast 2025-2030 ($ million)
- Chart on UK - Year-over-year growth 2025-2030 (%)
- Data Table on UK - Year-over-year growth 2025-2030 (%)
- Chart on France - Market size and forecast 2025-2030 ($ million)
- Data Table on France - Market size and forecast 2025-2030 ($ million)
- Chart on France - Year-over-year growth 2025-2030 (%)
- Data Table on France - Year-over-year growth 2025-2030 (%)
- Chart on Italy - Market size and forecast 2025-2030 ($ million)
- Data Table on Italy - Market size and forecast 2025-2030 ($ million)
- Chart on Italy - Year-over-year growth 2025-2030 (%)
- Data Table on Italy - Year-over-year growth 2025-2030 (%)
- Chart on Spain - Market size and forecast 2025-2030 ($ million)
- Data Table on Spain - Market size and forecast 2025-2030 ($ million)
- Chart on Spain - Year-over-year growth 2025-2030 (%)
- Data Table on Spain - Year-over-year growth 2025-2030 (%)
- Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
- Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
- Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
- Chart on Asia - Market size and forecast 2025-2030 ($ million)
- Data Table on Asia - Market size and forecast 2025-2030 ($ million)
- Chart on Asia - Year-over-year growth 2025-2030 (%)
- Data Table on Asia - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Asia
- Data Table on Regional Comparison - Asia
- Chart on China - Market size and forecast 2025-2030 ($ million)
- Data Table on China - Market size and forecast 2025-2030 ($ million)
- Chart on China - Year-over-year growth 2025-2030 (%)
- Data Table on China - Year-over-year growth 2025-2030 (%)
- Chart on Japan - Market size and forecast 2025-2030 ($ million)
- Data Table on Japan - Market size and forecast 2025-2030 ($ million)
- Chart on Japan - Year-over-year growth 2025-2030 (%)
- Data Table on Japan - Year-over-year growth 2025-2030 (%)
- Chart on India - Market size and forecast 2025-2030 ($ million)
- Data Table on India - Market size and forecast 2025-2030 ($ million)
- Chart on India - Year-over-year growth 2025-2030 (%)
- Data Table on India - Year-over-year growth 2025-2030 (%)
- Chart on South Korea - Market size and forecast 2025-2030 ($ million)
- Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
- Chart on South Korea - Year-over-year growth 2025-2030 (%)
- Data Table on South Korea - Year-over-year growth 2025-2030 (%)
- Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
- Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
- Chart on Indonesia - Year-over-year growth 2025-2030 (%)
- Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
- Chart on Thailand - Market size and forecast 2025-2030 ($ million)
- Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
- Chart on Thailand - Year-over-year growth 2025-2030 (%)
- Data Table on Thailand - Year-over-year growth 2025-2030 (%)
- Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
- Chart on Regional Comparison - Rest of World (ROW)
- Data Table on Regional Comparison - Rest of World (ROW)
- Chart on Brazil - Market size and forecast 2025-2030 ($ million)
- Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
- Chart on Brazil - Year-over-year growth 2025-2030 (%)
- Data Table on Brazil - Year-over-year growth 2025-2030 (%)
- Chart on Argentina - Market size and forecast 2025-2030 ($ million)
- Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
- Chart on Argentina - Year-over-year growth 2025-2030 (%)
- Data Table on Argentina - Year-over-year growth 2025-2030 (%)
- Chart on South Africa - Market size and forecast 2025-2030 ($ million)
- Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
- Chart on South Africa - Year-over-year growth 2025-2030 (%)
- Data Table on South Africa - Year-over-year growth 2025-2030 (%)
- Chart on UAE - Market size and forecast 2025-2030 ($ million)
- Data Table on UAE - Market size and forecast 2025-2030 ($ million)
- Chart on UAE - Year-over-year growth 2025-2030 (%)
- Data Table on UAE - Year-over-year growth 2025-2030 (%)
- Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
- Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
- Chart on Turkey - Market size and forecast 2025-2030 ($ million)
- Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
- Chart on Turkey - Year-over-year growth 2025-2030 (%)
- Data Table on Turkey - Year-over-year growth 2025-2030 (%)
- Chart on Colombia - Market size and forecast 2025-2030 ($ million)
- Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
- Chart on Colombia - Year-over-year growth 2025-2030 (%)
- Data Table on Colombia - Year-over-year growth 2025-2030 (%)
- Chart on Egypt - Market size and forecast 2025-2030 ($ million)
- Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
- Chart on Egypt - Year-over-year growth 2025-2030 (%)
- Data Table on Egypt - Year-over-year growth 2025-2030 (%)
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
- Increasing prevalence of chronic systemic and dermatological diseases
- Robust clinical pipelines and advancements in targeted biologic therapies
- Strategic licensing agreements and high value acquisitions expanding global reach
- High cost of advanced biologic therapies and stringent reimbursement policies
- Underdiagnosis and lack of standardized diagnostic modalities
- Complex health technology assessments and stringent regulatory pathways
- Impact of drivers and challenges in 2025 and 2030
- Accelerated shift toward nonsteroidal topical innovations
- Strategic expansion of targeted biologics into idiopathic and unexplained itch syndromes
- Rising prominence of precision therapeutics for systemic and renal pruritus management
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- Overview on factors of disruption
- Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
- Companies covered
- Company ranking index
- Matrix on companies position and classification
- AbbVie Inc. - Overview
- AbbVie Inc. - Business segments
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- AbbVie Inc. - Segment focus
- SWOT
- Almirall SA - Overview
- Almirall SA - Business segments
- Almirall SA - Key offerings
- Almirall SA - Segment focus
- SWOT
- Bausch Health Companies Inc. - Overview
- Bausch Health Companies Inc. - Business segments
- Bausch Health Companies Inc. - Key offerings
- Bausch Health Companies Inc. - Segment focus
- SWOT
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
- SWOT
- Galderma Group AG - Overview
- Galderma Group AG - Business segments
- Galderma Group AG - Key offerings
- Galderma Group AG - Segment focus
- SWOT
- Incyte Corp. - Overview
- Incyte Corp. - Product / Service
- Incyte Corp. - Key news
- Incyte Corp. - Key offerings
- SWOT
- Kiniksa Pharmaceuticals Ltd. - Overview
- Kiniksa Pharmaceuticals Ltd. - Product / Service
- Kiniksa Pharmaceuticals Ltd. - Key offerings
- SWOT
- Kissei Pharmaceutical Co. Ltd. - Overview
- Kissei Pharmaceutical Co. Ltd. - Business segments
- Kissei Pharmaceutical Co. Ltd. - Key offerings
- Kissei Pharmaceutical Co. Ltd. - Segment focus
- SWOT
- Pfizer Inc. - Overview
- Pfizer Inc. - Business segments
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- Pfizer Inc. - Segment focus
- SWOT
- Regeneron Pharmaceuticals Inc. - Overview
- Regeneron Pharmaceuticals Inc. - Product / Service
- Regeneron Pharmaceuticals Inc. - Key news
- Regeneron Pharmaceuticals Inc. - Key offerings
- SWOT
- Sanofi SA - Overview
- Sanofi SA - Business segments
- Sanofi SA - Key news
- Sanofi SA - Key offerings
- Sanofi SA - Segment focus
- SWOT
- Taiho Pharmaceutical Co. Ltd. - Overview
- Taiho Pharmaceutical Co. Ltd. - Product / Service
- Taiho Pharmaceutical Co. Ltd. - Key offerings
- SWOT
- Toray Industries Inc. - Overview
- Toray Industries Inc. - Business segments
- Toray Industries Inc. - Key news
- Toray Industries Inc. - Key offerings
- Toray Industries Inc. - Segment focus
- SWOT
- Vanda Pharmaceuticals Inc. - Overview
- Vanda Pharmaceuticals Inc. - Product / Service
- Vanda Pharmaceuticals Inc. - Key news
- Vanda Pharmaceuticals Inc. - Key offerings
- SWOT
16 Appendix
16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- Inclusions checklist
- Exclusions checklist
- Currency conversion rates for US$
- Research methodology
- Information sources
- Data validation
- Validation techniques employed for market sizing
- Data synthesis
- 360 degree market analysis
- List of abbreviations
List of Exhibits
Exhibit 1: Executive Summary - Chart on Market Overview
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Pruritus Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Application - Market share 2025-2030 (%)
Exhibit 39: Data Table on Application - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Application
Exhibit 41: Data Table on Comparison by Application
Exhibit 42: Chart on Hematologic pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hematologic pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hematologic pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hematologic pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Oncological pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Oncological pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Oncological pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Oncological pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Renal pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Renal pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Renal pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Renal pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Endocrine pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Endocrine pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Endocrine pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Endocrine pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Cholestatic pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Cholestatic pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Cholestatic pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Cholestatic pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Application ($ million)
Exhibit 63: Data Table on Market opportunity by Application ($ million)
Exhibit 64: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 65: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Route of Administration
Exhibit 67: Data Table on Comparison by Route of Administration
Exhibit 68: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 84: Market opportunity by Route of Administration ($ million)
Exhibit 85: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 86: Chart on End-user - Market share 2025-2030 (%)
Exhibit 87: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 88: Chart on Comparison by End-user
Exhibit 89: Data Table on Comparison by End-user
Exhibit 90: Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Homecare - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Homecare - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Homecare - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Homecare - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Specialty Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Specialty Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Specialty Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Specialty Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 102: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 105: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 106: Market opportunity by End-user ($ million)
Exhibit 107: Data Table on Market opportunity by End-user ($ million)
Exhibit 108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 109: Chart on Market share by geography 2025-2030 (%)
Exhibit 110: Data Table on Market share by geography 2025-2030 (%)
Exhibit 111: Chart on Geographic comparison
Exhibit 112: Data Table on Geographic comparison
Exhibit 113: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on Regional Comparison - North America
Exhibit 118: Data Table on Regional Comparison - North America
Exhibit 119: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 133: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Regional Comparison - Europe
Exhibit 136: Data Table on Regional Comparison - Europe
Exhibit 137: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Regional Comparison - Asia
Exhibit 166: Data Table on Regional Comparison - Asia
Exhibit 167: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 229: Market opportunity by geography ($ million)
Exhibit 230: Data Tables on Market opportunity by geography ($ million)
Exhibit 231: Impact of drivers and challenges in 2025 and 2030
Exhibit 232: Overview on criticality of inputs and factors of differentiation
Exhibit 233: Overview on factors of disruption
Exhibit 234: Impact of key risks on business
Exhibit 235: Companies covered
Exhibit 236: Company ranking index
Exhibit 237: Matrix on companies position and classification
Exhibit 238: AbbVie Inc. - Overview
Exhibit 239: AbbVie Inc. - Business segments
Exhibit 240: AbbVie Inc. - Key news
Exhibit 241: AbbVie Inc. - Key offerings
Exhibit 242: AbbVie Inc. - Segment focus
Exhibit 243: SWOT
Exhibit 244: Almirall SA - Overview
Exhibit 245: Almirall SA - Business segments
Exhibit 246: Almirall SA - Key offerings
Exhibit 247: Almirall SA - Segment focus
Exhibit 248: SWOT
Exhibit 249: Bausch Health Companies Inc. - Overview
Exhibit 250: Bausch Health Companies Inc. - Business segments
Exhibit 251: Bausch Health Companies Inc. - Key offerings
Exhibit 252: Bausch Health Companies Inc. - Segment focus
Exhibit 253: SWOT
Exhibit 254: Bristol Myers Squibb Co. - Overview
Exhibit 255: Bristol Myers Squibb Co. - Product / Service
Exhibit 256: Bristol Myers Squibb Co. - Key news
Exhibit 257: Bristol Myers Squibb Co. - Key offerings
Exhibit 258: SWOT
Exhibit 259: CSL Ltd. - Overview
Exhibit 260: CSL Ltd. - Business segments
Exhibit 261: CSL Ltd. - Key news
Exhibit 262: CSL Ltd. - Key offerings
Exhibit 263: CSL Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: Galderma Group AG - Overview
Exhibit 266: Galderma Group AG - Business segments
Exhibit 267: Galderma Group AG - Key offerings
Exhibit 268: Galderma Group AG - Segment focus
Exhibit 269: SWOT
Exhibit 270: Incyte Corp. - Overview
Exhibit 271: Incyte Corp. - Product / Service
Exhibit 272: Incyte Corp. - Key news
Exhibit 273: Incyte Corp. - Key offerings
Exhibit 274: SWOT
Exhibit 275: Kiniksa Pharmaceuticals Ltd. - Overview
Exhibit 276: Kiniksa Pharmaceuticals Ltd. - Product / Service
Exhibit 277: Kiniksa Pharmaceuticals Ltd. - Key offerings
Exhibit 278: SWOT
Exhibit 279: Kissei Pharmaceutical Co. Ltd. - Overview
Exhibit 280: Kissei Pharmaceutical Co. Ltd. - Business segments
Exhibit 281: Kissei Pharmaceutical Co. Ltd. - Key offerings
Exhibit 282: Kissei Pharmaceutical Co. Ltd. - Segment focus
Exhibit 283: SWOT
Exhibit 284: Pfizer Inc. - Overview
Exhibit 285: Pfizer Inc. - Business segments
Exhibit 286: Pfizer Inc. - Key news
Exhibit 287: Pfizer Inc. - Key offerings
Exhibit 288: Pfizer Inc. - Segment focus
Exhibit 289: SWOT
Exhibit 290: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 291: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 292: Regeneron Pharmaceuticals Inc. - Key news
Exhibit 293: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibit 294: SWOT
Exhibit 295: Sanofi SA - Overview
Exhibit 296: Sanofi SA - Business segments
Exhibit 297: Sanofi SA - Key news
Exhibit 298: Sanofi SA - Key offerings
Exhibit 299: Sanofi SA - Segment focus
Exhibit 300: SWOT
Exhibit 301: Taiho Pharmaceutical Co. Ltd. - Overview
Exhibit 302: Taiho Pharmaceutical Co. Ltd. - Product / Service
Exhibit 303: Taiho Pharmaceutical Co. Ltd. - Key offerings
Exhibit 304: SWOT
Exhibit 305: Toray Industries Inc. - Overview
Exhibit 306: Toray Industries Inc. - Business segments
Exhibit 307: Toray Industries Inc. - Key news
Exhibit 308: Toray Industries Inc. - Key offerings
Exhibit 309: Toray Industries Inc. - Segment focus
Exhibit 310: SWOT
Exhibit 311: Vanda Pharmaceuticals Inc. - Overview
Exhibit 312: Vanda Pharmaceuticals Inc. - Product / Service
Exhibit 313: Vanda Pharmaceuticals Inc. - Key news
Exhibit 314: Vanda Pharmaceuticals Inc. - Key offerings
Exhibit 315: SWOT
Exhibit 316: Inclusions checklist
Exhibit 317: Exclusions checklist
Exhibit 318: Currency conversion rates for US$
Exhibit 319: Research methodology
Exhibit 320: Information sources
Exhibit 321: Data validation
Exhibit 322: Validation techniques employed for market sizing
Exhibit 323: Data synthesis
Exhibit 324: 360 degree market analysis
Exhibit 325: List of abbreviations
Exhibit 2: Executive Summary - Data Table on Market Overview
Exhibit 3: Executive Summary - Chart on Global Market Characteristics
Exhibit 4: Executive Summary - Chart on Market by Geography
Exhibit 5: Executive Summary - Chart on Market Segmentation by Application
Exhibit 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 7: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 8: Executive Summary - Chart on Incremental Growth
Exhibit 9: Executive Summary - Data Table on Incremental Growth
Exhibit 10: Executive Summary - Chart on Company Market Positioning
Exhibit 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 12: Chart on Overview on criticality of inputs and factors of differentiation
Exhibit 13: Chart on Overview on factors of disruption
Exhibit 14: Chart on Impact of drivers and challenges in 2025 and 2030
Exhibit 15: Chart on Parent Market
Exhibit 16: Data Table on - Parent Market
Exhibit 17: Chart on Market characteristics analysis
Exhibit 18: Chart on Value chain analysis
Exhibit 19: Data Table on Offerings of companies included in the market definition
Exhibit 20: Market segments
Exhibit 21: Chart on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 22: Data Table on Global - Market size and forecast 2025-2030 ($ million)
Exhibit 23: Chart on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 24: Data Table on Global Market: Year-over-year growth 2025-2030 (%)
Exhibit 25: Historic Market Size - Data Table on Global Pruritus Drugs Market 2020 - 2024 ($ million)
Exhibit 26: Historic Market Size - Application Segment 2020 - 2024 ($ million)
Exhibit 27: Historic Market Size - Route of Administration Segment 2020 - 2024 ($ million)
Exhibit 28: Historic Market Size - End-user Segment 2020 - 2024 ($ million)
Exhibit 29: Historic Market Size - Geography Segment 2020 - 2024 ($ million)
Exhibit 30: Historic Market Size - Country Segment 2020 - 2024 ($ million)
Exhibit 31: Five forces analysis - Comparison between 2025 and 2030
Exhibit 32: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibit 33: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibit 34: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibit 35: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibit 36: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibit 37: Chart on Market condition - Five forces 2025 and 2030
Exhibit 38: Chart on Application - Market share 2025-2030 (%)
Exhibit 39: Data Table on Application - Market share 2025-2030 (%)
Exhibit 40: Chart on Comparison by Application
Exhibit 41: Data Table on Comparison by Application
Exhibit 42: Chart on Hematologic pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 43: Data Table on Hematologic pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 44: Chart on Hematologic pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 45: Data Table on Hematologic pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 46: Chart on Oncological pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 47: Data Table on Oncological pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 48: Chart on Oncological pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 49: Data Table on Oncological pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 50: Chart on Renal pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 51: Data Table on Renal pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 52: Chart on Renal pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 53: Data Table on Renal pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 54: Chart on Endocrine pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 55: Data Table on Endocrine pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 56: Chart on Endocrine pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 57: Data Table on Endocrine pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 58: Chart on Cholestatic pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 59: Data Table on Cholestatic pruritus - Market size and forecast 2025-2030 ($ million)
Exhibit 60: Chart on Cholestatic pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 61: Data Table on Cholestatic pruritus - Year-over-year growth 2025-2030 (%)
Exhibit 62: Market opportunity by Application ($ million)
Exhibit 63: Data Table on Market opportunity by Application ($ million)
Exhibit 64: Chart on Route of Administration - Market share 2025-2030 (%)
Exhibit 65: Data Table on Route of Administration - Market share 2025-2030 (%)
Exhibit 66: Chart on Comparison by Route of Administration
Exhibit 67: Data Table on Comparison by Route of Administration
Exhibit 68: Chart on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 69: Data Table on Oral - Market size and forecast 2025-2030 ($ million)
Exhibit 70: Chart on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 71: Data Table on Oral - Year-over-year growth 2025-2030 (%)
Exhibit 72: Chart on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 73: Data Table on Topical - Market size and forecast 2025-2030 ($ million)
Exhibit 74: Chart on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 75: Data Table on Topical - Year-over-year growth 2025-2030 (%)
Exhibit 76: Chart on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 77: Data Table on Injectable - Market size and forecast 2025-2030 ($ million)
Exhibit 78: Chart on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 79: Data Table on Injectable - Year-over-year growth 2025-2030 (%)
Exhibit 80: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 81: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 82: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 83: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 84: Market opportunity by Route of Administration ($ million)
Exhibit 85: Data Table on Market opportunity by Route of Administration ($ million)
Exhibit 86: Chart on End-user - Market share 2025-2030 (%)
Exhibit 87: Data Table on End-user - Market share 2025-2030 (%)
Exhibit 88: Chart on Comparison by End-user
Exhibit 89: Data Table on Comparison by End-user
Exhibit 90: Chart on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 91: Data Table on Hospitals - Market size and forecast 2025-2030 ($ million)
Exhibit 92: Chart on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 93: Data Table on Hospitals - Year-over-year growth 2025-2030 (%)
Exhibit 94: Chart on Homecare - Market size and forecast 2025-2030 ($ million)
Exhibit 95: Data Table on Homecare - Market size and forecast 2025-2030 ($ million)
Exhibit 96: Chart on Homecare - Year-over-year growth 2025-2030 (%)
Exhibit 97: Data Table on Homecare - Year-over-year growth 2025-2030 (%)
Exhibit 98: Chart on Specialty Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 99: Data Table on Specialty Clinics - Market size and forecast 2025-2030 ($ million)
Exhibit 100: Chart on Specialty Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 101: Data Table on Specialty Clinics - Year-over-year growth 2025-2030 (%)
Exhibit 102: Chart on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 103: Data Table on Others - Market size and forecast 2025-2030 ($ million)
Exhibit 104: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibit 105: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibit 106: Market opportunity by End-user ($ million)
Exhibit 107: Data Table on Market opportunity by End-user ($ million)
Exhibit 108: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibit 109: Chart on Market share by geography 2025-2030 (%)
Exhibit 110: Data Table on Market share by geography 2025-2030 (%)
Exhibit 111: Chart on Geographic comparison
Exhibit 112: Data Table on Geographic comparison
Exhibit 113: Chart on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 114: Data Table on North America - Market size and forecast 2025-2030 ($ million)
Exhibit 115: Chart on North America - Year-over-year growth 2025-2030 (%)
Exhibit 116: Data Table on North America - Year-over-year growth 2025-2030 (%)
Exhibit 117: Chart on Regional Comparison - North America
Exhibit 118: Data Table on Regional Comparison - North America
Exhibit 119: Chart on US - Market size and forecast 2025-2030 ($ million)
Exhibit 120: Data Table on US - Market size and forecast 2025-2030 ($ million)
Exhibit 121: Chart on US - Year-over-year growth 2025-2030 (%)
Exhibit 122: Data Table on US - Year-over-year growth 2025-2030 (%)
Exhibit 123: Chart on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 124: Data Table on Canada - Market size and forecast 2025-2030 ($ million)
Exhibit 125: Chart on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 126: Data Table on Canada - Year-over-year growth 2025-2030 (%)
Exhibit 127: Chart on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 128: Data Table on Mexico - Market size and forecast 2025-2030 ($ million)
Exhibit 129: Chart on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 130: Data Table on Mexico - Year-over-year growth 2025-2030 (%)
Exhibit 131: Chart on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 132: Data Table on Europe - Market size and forecast 2025-2030 ($ million)
Exhibit 133: Chart on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 134: Data Table on Europe - Year-over-year growth 2025-2030 (%)
Exhibit 135: Chart on Regional Comparison - Europe
Exhibit 136: Data Table on Regional Comparison - Europe
Exhibit 137: Chart on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 138: Data Table on Germany - Market size and forecast 2025-2030 ($ million)
Exhibit 139: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 140: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibit 141: Chart on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 142: Data Table on UK - Market size and forecast 2025-2030 ($ million)
Exhibit 143: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibit 144: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibit 145: Chart on France - Market size and forecast 2025-2030 ($ million)
Exhibit 146: Data Table on France - Market size and forecast 2025-2030 ($ million)
Exhibit 147: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibit 148: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibit 149: Chart on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 150: Data Table on Italy - Market size and forecast 2025-2030 ($ million)
Exhibit 151: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 152: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibit 153: Chart on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 154: Data Table on Spain - Market size and forecast 2025-2030 ($ million)
Exhibit 155: Chart on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 156: Data Table on Spain - Year-over-year growth 2025-2030 (%)
Exhibit 157: Chart on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 158: Data Table on The Netherlands - Market size and forecast 2025-2030 ($ million)
Exhibit 159: Chart on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 160: Data Table on The Netherlands - Year-over-year growth 2025-2030 (%)
Exhibit 161: Chart on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 162: Data Table on Asia - Market size and forecast 2025-2030 ($ million)
Exhibit 163: Chart on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 164: Data Table on Asia - Year-over-year growth 2025-2030 (%)
Exhibit 165: Chart on Regional Comparison - Asia
Exhibit 166: Data Table on Regional Comparison - Asia
Exhibit 167: Chart on China - Market size and forecast 2025-2030 ($ million)
Exhibit 168: Data Table on China - Market size and forecast 2025-2030 ($ million)
Exhibit 169: Chart on China - Year-over-year growth 2025-2030 (%)
Exhibit 170: Data Table on China - Year-over-year growth 2025-2030 (%)
Exhibit 171: Chart on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 172: Data Table on Japan - Market size and forecast 2025-2030 ($ million)
Exhibit 173: Chart on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 174: Data Table on Japan - Year-over-year growth 2025-2030 (%)
Exhibit 175: Chart on India - Market size and forecast 2025-2030 ($ million)
Exhibit 176: Data Table on India - Market size and forecast 2025-2030 ($ million)
Exhibit 177: Chart on India - Year-over-year growth 2025-2030 (%)
Exhibit 178: Data Table on India - Year-over-year growth 2025-2030 (%)
Exhibit 179: Chart on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 180: Data Table on South Korea - Market size and forecast 2025-2030 ($ million)
Exhibit 181: Chart on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 182: Data Table on South Korea - Year-over-year growth 2025-2030 (%)
Exhibit 183: Chart on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 184: Data Table on Indonesia - Market size and forecast 2025-2030 ($ million)
Exhibit 185: Chart on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 186: Data Table on Indonesia - Year-over-year growth 2025-2030 (%)
Exhibit 187: Chart on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 188: Data Table on Thailand - Market size and forecast 2025-2030 ($ million)
Exhibit 189: Chart on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 190: Data Table on Thailand - Year-over-year growth 2025-2030 (%)
Exhibit 191: Chart on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 192: Data Table on Rest of World (ROW) - Market size and forecast 2025-2030 ($ million)
Exhibit 193: Chart on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 194: Data Table on Rest of World (ROW) - Year-over-year growth 2025-2030 (%)
Exhibit 195: Chart on Regional Comparison - Rest of World (ROW)
Exhibit 196: Data Table on Regional Comparison - Rest of World (ROW)
Exhibit 197: Chart on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 198: Data Table on Brazil - Market size and forecast 2025-2030 ($ million)
Exhibit 199: Chart on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 200: Data Table on Brazil - Year-over-year growth 2025-2030 (%)
Exhibit 201: Chart on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 202: Data Table on Argentina - Market size and forecast 2025-2030 ($ million)
Exhibit 203: Chart on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 204: Data Table on Argentina - Year-over-year growth 2025-2030 (%)
Exhibit 205: Chart on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 206: Data Table on South Africa - Market size and forecast 2025-2030 ($ million)
Exhibit 207: Chart on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 208: Data Table on South Africa - Year-over-year growth 2025-2030 (%)
Exhibit 209: Chart on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 210: Data Table on UAE - Market size and forecast 2025-2030 ($ million)
Exhibit 211: Chart on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 212: Data Table on UAE - Year-over-year growth 2025-2030 (%)
Exhibit 213: Chart on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 214: Data Table on Saudi Arabia - Market size and forecast 2025-2030 ($ million)
Exhibit 215: Chart on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 216: Data Table on Saudi Arabia - Year-over-year growth 2025-2030 (%)
Exhibit 217: Chart on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 218: Data Table on Turkey - Market size and forecast 2025-2030 ($ million)
Exhibit 219: Chart on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 220: Data Table on Turkey - Year-over-year growth 2025-2030 (%)
Exhibit 221: Chart on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 222: Data Table on Colombia - Market size and forecast 2025-2030 ($ million)
Exhibit 223: Chart on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 224: Data Table on Colombia - Year-over-year growth 2025-2030 (%)
Exhibit 225: Chart on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 226: Data Table on Egypt - Market size and forecast 2025-2030 ($ million)
Exhibit 227: Chart on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 228: Data Table on Egypt - Year-over-year growth 2025-2030 (%)
Exhibit 229: Market opportunity by geography ($ million)
Exhibit 230: Data Tables on Market opportunity by geography ($ million)
Exhibit 231: Impact of drivers and challenges in 2025 and 2030
Exhibit 232: Overview on criticality of inputs and factors of differentiation
Exhibit 233: Overview on factors of disruption
Exhibit 234: Impact of key risks on business
Exhibit 235: Companies covered
Exhibit 236: Company ranking index
Exhibit 237: Matrix on companies position and classification
Exhibit 238: AbbVie Inc. - Overview
Exhibit 239: AbbVie Inc. - Business segments
Exhibit 240: AbbVie Inc. - Key news
Exhibit 241: AbbVie Inc. - Key offerings
Exhibit 242: AbbVie Inc. - Segment focus
Exhibit 243: SWOT
Exhibit 244: Almirall SA - Overview
Exhibit 245: Almirall SA - Business segments
Exhibit 246: Almirall SA - Key offerings
Exhibit 247: Almirall SA - Segment focus
Exhibit 248: SWOT
Exhibit 249: Bausch Health Companies Inc. - Overview
Exhibit 250: Bausch Health Companies Inc. - Business segments
Exhibit 251: Bausch Health Companies Inc. - Key offerings
Exhibit 252: Bausch Health Companies Inc. - Segment focus
Exhibit 253: SWOT
Exhibit 254: Bristol Myers Squibb Co. - Overview
Exhibit 255: Bristol Myers Squibb Co. - Product / Service
Exhibit 256: Bristol Myers Squibb Co. - Key news
Exhibit 257: Bristol Myers Squibb Co. - Key offerings
Exhibit 258: SWOT
Exhibit 259: CSL Ltd. - Overview
Exhibit 260: CSL Ltd. - Business segments
Exhibit 261: CSL Ltd. - Key news
Exhibit 262: CSL Ltd. - Key offerings
Exhibit 263: CSL Ltd. - Segment focus
Exhibit 264: SWOT
Exhibit 265: Galderma Group AG - Overview
Exhibit 266: Galderma Group AG - Business segments
Exhibit 267: Galderma Group AG - Key offerings
Exhibit 268: Galderma Group AG - Segment focus
Exhibit 269: SWOT
Exhibit 270: Incyte Corp. - Overview
Exhibit 271: Incyte Corp. - Product / Service
Exhibit 272: Incyte Corp. - Key news
Exhibit 273: Incyte Corp. - Key offerings
Exhibit 274: SWOT
Exhibit 275: Kiniksa Pharmaceuticals Ltd. - Overview
Exhibit 276: Kiniksa Pharmaceuticals Ltd. - Product / Service
Exhibit 277: Kiniksa Pharmaceuticals Ltd. - Key offerings
Exhibit 278: SWOT
Exhibit 279: Kissei Pharmaceutical Co. Ltd. - Overview
Exhibit 280: Kissei Pharmaceutical Co. Ltd. - Business segments
Exhibit 281: Kissei Pharmaceutical Co. Ltd. - Key offerings
Exhibit 282: Kissei Pharmaceutical Co. Ltd. - Segment focus
Exhibit 283: SWOT
Exhibit 284: Pfizer Inc. - Overview
Exhibit 285: Pfizer Inc. - Business segments
Exhibit 286: Pfizer Inc. - Key news
Exhibit 287: Pfizer Inc. - Key offerings
Exhibit 288: Pfizer Inc. - Segment focus
Exhibit 289: SWOT
Exhibit 290: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 291: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 292: Regeneron Pharmaceuticals Inc. - Key news
Exhibit 293: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibit 294: SWOT
Exhibit 295: Sanofi SA - Overview
Exhibit 296: Sanofi SA - Business segments
Exhibit 297: Sanofi SA - Key news
Exhibit 298: Sanofi SA - Key offerings
Exhibit 299: Sanofi SA - Segment focus
Exhibit 300: SWOT
Exhibit 301: Taiho Pharmaceutical Co. Ltd. - Overview
Exhibit 302: Taiho Pharmaceutical Co. Ltd. - Product / Service
Exhibit 303: Taiho Pharmaceutical Co. Ltd. - Key offerings
Exhibit 304: SWOT
Exhibit 305: Toray Industries Inc. - Overview
Exhibit 306: Toray Industries Inc. - Business segments
Exhibit 307: Toray Industries Inc. - Key news
Exhibit 308: Toray Industries Inc. - Key offerings
Exhibit 309: Toray Industries Inc. - Segment focus
Exhibit 310: SWOT
Exhibit 311: Vanda Pharmaceuticals Inc. - Overview
Exhibit 312: Vanda Pharmaceuticals Inc. - Product / Service
Exhibit 313: Vanda Pharmaceuticals Inc. - Key news
Exhibit 314: Vanda Pharmaceuticals Inc. - Key offerings
Exhibit 315: SWOT
Exhibit 316: Inclusions checklist
Exhibit 317: Exclusions checklist
Exhibit 318: Currency conversion rates for US$
Exhibit 319: Research methodology
Exhibit 320: Information sources
Exhibit 321: Data validation
Exhibit 322: Validation techniques employed for market sizing
Exhibit 323: Data synthesis
Exhibit 324: 360 degree market analysis
Exhibit 325: List of abbreviations
Executive Summary
The following companies are recognized as the key players in the global global pruritus drugs market: AbbVie Inc., Almirall SA, Bausch Health Companies Inc., Bristol Myers Squibb Co., CSL Ltd., Escient Pharmaceuticals, Galderma Group AG, Incyte Corp., Kiniksa Pharmaceuticals Ltd., Kissei Pharmaceutical Co. Ltd., LEO Pharma AS, Maruho Co. Ltd., Pfizer Inc., Regeneron Pharmaceuticals Inc., Sanofi SA, Taiho Pharmaceutical Co. Ltd., Toray Industries Inc., Tvardi Therapeutics Inc., Vanda Pharmaceuticals Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is accelerated shift toward nonsteroidal topical innovations."
According to the report, one of the major drivers for this market is the increasing prevalence of chronic systemic and dermatological diseases.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Almirall SA
- Bausch Health Companies Inc.
- Bristol Myers Squibb Co.
- CSL Ltd.
- Escient Pharmaceuticals
- Galderma Group AG
- Incyte Corp.
- Kiniksa Pharmaceuticals Ltd.
- Kissei Pharmaceutical Co. Ltd.
- LEO Pharma AS
- Maruho Co. Ltd.
- Pfizer Inc.
- Regeneron Pharmaceuticals Inc.
- Sanofi SA
- Taiho Pharmaceutical Co. Ltd.
- Toray Industries Inc.
- Tvardi Therapeutics Inc.
- Vanda Pharmaceuticals Inc.
